Monte Rosa Therapeutics to Present Updated MRT-2359 Phase 1/2 Study Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/16/2026

1. AMAT
2. SPY
3. GLOB
4. RDDT
5. HTFL
6. SNDK
7. WDAY
8. ADYEN:NA
9. DVLT
10. ADYYF

Go back to Monte Rosa Therapeutics to Present Updated MRT-2359 Phase 1/2 Study Results
(NASDAQ: GLUE) Delayed: 15.50 -0.34 (2.15%)
Previous Close $15.84    52 Week High $ 
Open $15.72    52 Week Low $ 
Day High $15.83    P/E N/A 
Day Low $15.37    EPS $ 
Volume 509,501